Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Yoshimura

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Biophysics and Physicobiology|June 29, 2026
Oligo DNA-based quantum dot (QD) single-particle tracking for multicolor single-molecule imagingShigeo Sakuragi, Naoki Kato, Tomoya Uchida, et al.
Molecular and Clinical Oncology|November 7, 2019
Trend of salvage treatment in diffuse large B cell lymphoma in the outpatient chemotherapy eraAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Transplantation and Cellular Therapy|May 14, 2021
Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell TransplantationMasaaki Hotta, Atsushi Satake, Hideaki Yoshimura, et al.
Transplant Immunology|November 1, 2019
Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantationShosaku Nomura, Akiko Konishi, Yukie Tsubokura, et al.
Chemical Science|June 13, 2022
Discovery of a phase-separating small molecule that selectively sequesters tubulin in cellsGenyir Ado, Naotaka Noda, Hue T Vu, et al.
Hematology Reports|October 4, 2019
A variant of acute promyelocytic leukemia with t(4;17)(q12;q21) showed two different clinical symptomsTakahisa Nakanishi, Aya Nakaya, Yusuke Nishio, et al.
International Journal of Hematology|April 25, 2020
Comparison of starting doses of anagrelide as a first-line therapy in patients with cytoreductive therapy-naïve essential thrombocythemia: difference between starting at 0.5 and 1.0 mg/dayYoshinori Hashimoto, Tomoki Ito, Yasuhiro Tanaka, et al.
European Journal of Haematology|May 21, 2019
Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naïve essential thrombocythemia patients in a real-world settingTomoki Ito, Yoshinori Hashimoto, Yasuhiro Tanaka, et al.
Journal of the American Chemical Society|October 1, 2025
Live-Cell Monitoring and Omics Analysis of Liquid-Solid Transitions of Biomolecular CondensatesAsmaa M A S Farrag, Koshiro Ota, Hideaki Yoshimura, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Biophysics and Physicobiology|June 29, 2026
Oligo DNA-based quantum dot (QD) single-particle tracking for multicolor single-molecule imagingShigeo Sakuragi, Naoki Kato, Tomoya Uchida, et al.
Molecular and Clinical Oncology|November 7, 2019
Trend of salvage treatment in diffuse large B cell lymphoma in the outpatient chemotherapy eraAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Transplantation and Cellular Therapy|May 14, 2021
Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell TransplantationMasaaki Hotta, Atsushi Satake, Hideaki Yoshimura, et al.
Transplant Immunology|November 1, 2019
Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantationShosaku Nomura, Akiko Konishi, Yukie Tsubokura, et al.
Chemical Science|June 13, 2022
Discovery of a phase-separating small molecule that selectively sequesters tubulin in cellsGenyir Ado, Naotaka Noda, Hue T Vu, et al.
Hematology Reports|October 4, 2019
A variant of acute promyelocytic leukemia with t(4;17)(q12;q21) showed two different clinical symptomsTakahisa Nakanishi, Aya Nakaya, Yusuke Nishio, et al.
International Journal of Hematology|April 25, 2020
Comparison of starting doses of anagrelide as a first-line therapy in patients with cytoreductive therapy-naïve essential thrombocythemia: difference between starting at 0.5 and 1.0 mg/dayYoshinori Hashimoto, Tomoki Ito, Yasuhiro Tanaka, et al.
European Journal of Haematology|May 21, 2019
Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naïve essential thrombocythemia patients in a real-world settingTomoki Ito, Yoshinori Hashimoto, Yasuhiro Tanaka, et al.
Journal of the American Chemical Society|October 1, 2025
Live-Cell Monitoring and Omics Analysis of Liquid-Solid Transitions of Biomolecular CondensatesAsmaa M A S Farrag, Koshiro Ota, Hideaki Yoshimura, et al.
Pageof 9